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A B S T R A C T
The pathogenesis of diabetic retinopathy (DR) is insufficiently understood and presumed to possibly involve inflam-
mation and endothelial dysfunction. The aim of the study was to investigate the relationship between inflammation
markers, other markers of endothelial dysfunction and anthropometric parameters and their association with DR in pa-
tients with type 2 diabetes, divided into three groups: no retinopathy (N=65), mild / moderate nonproliferative diabetic
retinopathy (NPDR; N=19) and severe NPDR / proliferative diabetic retinopathy (PDR; N=23). The groups did not dif-
fer in the levels of inflammation markers, other markers of endothelial dysfunction and anthropometric parameters.
C-reactive protein was correlated with fibrinogen, HbA1c, LDL-cholesterol, BMI, WC, WHR and C index. HbA1c was cor-
related with cholesterol, LDL-cholesterol, BMI and WC. Logistic regression analysis showed that diabetes duration and
HbA1cmedian were the main predictors of retinopathy. The study demonstrated that the association between obesity, in-
flammation and other risk factors plays an important role in endothelial impairment involved in the pathogenesis of DR.
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Introduction
Diabetes mellitus is the most frequent endocrine dis-
ease in developed countries, estimated to have affected
284.6 million people worldwide in 2010 and projected to
affect 438.4 million by 20301. It was the 5th leading cause
of death in 2000, and its complications account for a sig-
nificant portion of morbidity and mortality2. Diabetic
retinopathy (DR), a long-term microvascular and visu-
ally devastating diabetic complication, is estimated to be
the most frequent cause of new blindness among work-
ing-aged adults (20–74 years) in developed countries3,4.
Many epidemiological studies and clinical trials have
proven the impact of diabetes duration, poor glycemic
control, hypertension, hyperlipidemia and obesity on the
prevalence, incidence and progression of diabetic retino-
pathy5–8. However, these factors explain a small propor-
tion of the presence and progression of retinopathy, and
of the incidence of proliferative retinopathy9, whereas
exact pathogenesis of diabetic retinopathy is insufficien-
tly understood. Dysfunction of retinal endothelium is
thought to be a possible mechanism as it plays a crucial
role in all stages of diabetic retinopathy10,11. Strategically
located between blood and tissue, healthy endothelium
actively regulates vascular tone and permeability, the
balance between coagulation and fibrinolysis, the compo-
sition of the subendothelial matrix, the extravasation of
leukocytes, and the proliferation of vascular smooth
muscle. To perform these functions, endothelium pro-
duces components of the extracellular matrix and a vari-
ety of regulatory mediators. Functional impairment of
endothelial activity precedes the development of mor-
phological alterations during the progression of diabetes
and its vascular complications. This endothelial dysfunc-
tion results from reduced bioavailability of the vascular
nitric oxide (NO), mainly due to accelerated NO degrada-
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tion by reactive oxygen species (ROS). Although hyper-
glycemia, insulin resistance, hyperinsulinemia and hyper-
lipidemia independently and/or simultaneously contribute
to endothelial dysfunction via several different mecha-
nisms12, hemorheological alterations and systemic in-
flammation found in obese diabetic patients may play an
essential role in the endothelial dysfunction and the aeti-
ology of diabetic retinopathy13,14.
Many studies have documented the association of in-
flammation markers and endothelial dysfunction with
macroangiopathy in obese non-diabetic individuals and
type 2 diabetic patients15,16, but only some of them have
investigated the association of inflammation and endo-
thelial dysfunction with the prevalence and progression
of diabetic microangiopathy17,18.
The aim of the present study was to investigate the
relationship between inflammation markers, other mar-
kers of endothelial dysfunction and anthropometric pa-
rameters, and their association with diabetic retinopathy
in patients with type 2 diabetes.
Materials and Methods
This cross-sectional study was conducted in collabora-
tion between the Department of Endocrinology and Met-
abolic Diseases and the Department of Diabetic Compli-
cations, Division of Ophthalmology of the Vuk Vrhovac
University Clinic for Diabetes, Endocrinology and Meta-
bolic Diseases, Merkur University Hospital in Zagreb. A
total of 107 patients with type 2 diabetes consecutively
attending both Departments over a six-month period
were included. Their age ranged from 50 to 80 years, and
diabetes duration from 5 to 25 years. They were on either
oral hypoglycemic agent (OHA) therapy or insulin ther-
apy. Patients with malignancies, immunologic, infectious
inflammatory diseases, patients receiving corticosteroids
or cytostatics, pregnant women and patients with other
eye diseases (mature cataract, uveitis, age-related macu-
lar degeneration) were not included in the study. The
study protocol was approved by the Vuk Vrhovac Univer-
sity Clinic Ethics Committee. The patients received both
written and oral information about the study and signed
a written informed consent.
Markers of inflammation
C-reactive protein (CRP) was determined by an auto-
mated immunoturbidimetric assay on an Olympus AU600
analyzer (Olympus Optical Co., Tokyo, Japan) (reference
value <5.0 mg/L)19. Fibrinogen was measured by the
Clauss method (reference values 1.8–4.1 g/L)20.
Other markers of endothelial dysfunction
Glycated hemoglobin value (HbA1c), total cholesterol,
HDL cholesterol, LDL cholesterol and triglycerides were
measured. HbA1c was determined at the beginning of the
study from a single venous blood sample, and HbA1cmedian
was obtained by statistical analysis of data from the Na-
tional Registry for Diabetes (CroDiabNet). The statistical
analysis included HbA1c values from venous blood samples
taken from each individual patient at 3–4 month intervals
over the past three years. HbA1c was determined by an
automated immunoturbidimetric assay (reference values
3.5–5.7%)21. Total cholesterol was measured by an enzy-
matic colorimetric test (reference value <5.00 mmol/L)22,
HDL cholesterol by an enzymatic immunoinhibition test
(reference value >1.00 mmol/L)23, and LDL cholesterol by
Friedwald’s method (reference value <3.00 mmol/ L)24. Tri-
glycerides were determined by an enzymatic colorimetric
test (reference value <1.70 mmol/L)25.
Anthropometric parameters
Body mass index (BMI) as a common index of obesity
was calculated by dividing weight and height squared
(kg/m2). Weight was measured using a balance-beam
scale and height was measured using a wall-mounted
stadiometer with patients in their underwear and with-
out shoes. Recommended value among men was consid-
ered <23 and among women <22 kg/m2 with a normal
range between 18.5 and 24.9 kg/m2,26. Waist circumference
(WC), a direct indicator of abdominal obesity, was mea-
sured in the middle distance between the last floating rib
and the iliac crest (cm). Recommended values were con-
sidered <94 cm (men) and <80 cm (women)27. The waist-
-to-hip ratio (WHR) as an index of body fat distribution
was determined by dividing waist and hip circumference.
The hip circumference was measured with a measuring
tape passing on femoral trochanters (cm). Suggested val-
ues of WHR were considered as <1.0 (men) and <0.8
(women)27. The conicity index (C index), another index of
body fat distribution, was determined by measuring
weight, height and waist circumference and a density
constant 0.109 by using mathematical equation: WC (m)
/ 0.109 x v weight (kg) / height (m). The value of the C in-
dex varies between 1.00 (a perfect cylinder – an »ideal«
body fat distribution) and 1.73 (a perfect biconical shape
– huge abdominal obesity)28.
Clinical parameters
Blood pressure was measured with an ambulatory
sphygmomanometric device after a 5-min rest, and a
mean of three measurements was used. Hypertension
was defined as blood pressure >130/80 mm Hg.
Ophthalmologic examination
Complete eye examination included best corrected vi-
sual acuity (BCVA), Goldmann applanation tonometry,
slit lamp biomicroscopy of the anterior eye segment, bin-
ocular indirect slit lamp fundoscopy and fundus photog-
raphy after mydriasis with eye drops containing 0.5%
tropicamide and 5% phenylephrine. Color fundus photo-
graphs of two fields (macular field, disc/nasal field) of
both eyes were taken with a suitable 45° fundus camera
(VISUCAM, Zeiss) according to the EURODIAB retinal
photography methodology29. Macular field: positioned in
such a way that the exact center of the optic disc laid at
the nasal end of the horizontal meridian of the field view.
Disc/nasal field: such that the optic disc was positioned
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one disc-diameter in from the temporal edge of the field,
on the horizontal meridian. EURODIAB classification
scheme was used because it uses two-field 45° fundus
photography and standard photographs to grade retinal
lesions29. In each patient the »worse« eye was graded for
retinopathy using fundus photographs.
Statistical analyses
Results are presented as means± SD and percent-
ages. Differences in distributions of continuous data were
determined by ANOVA or Kruskal-Wallis test. Scheffe’s
post-hoc test was used. Differences in distributions of
categorical data were evaluated by Chi-square test or
Fisher exact test. The normality of distribution was
tested by Shapiro-Wilks W test and homogeneity of vari-
ance by Leven test. The Spearman rank correlation test
was used. Univariate and multiple logistic regression
analyses were used to assess the strength and independ-
ence of associations. All analyses were performed using
SAS 9.1.3 and STATA/IC ver.11.1. p value of less than
0.05 was considered statistically significant.
Results
This study included 107 patients with type 2 diabetes
(67 male, 40 female) with a mean age 66.74±8.01 years
and a mean diabetes duration of 15.05±5.69 years. Forty
(37%) patients were on oral hypoglycemic agents (OHA)
and 67 (63%) on insulin therapy.
The average best corrected visual acuity (BCVA) of
our patients was 0.91±0.22, and the average intraocular
pressure (IOP) was 13.55±1.33 mmHg. Nine (8%) pa-
tients were suffering from primary open angle glaucoma
(POAG) and were treated with topical antiglaucomatous
therapy. 16 (15%) patients had clear crystalline lenses, 74
(69%) an initial cataract and 17 (16%) patients had the
condition after cataract surgery (an artificial IOL im-
planted). Hypertensive retinopathy was detected in 40
(37%) patients.
According to the two-field 45° color fundus photogra-
phy (EURODIAB standards) patients were divided into
three groups: Group 1 – patients with no retinopathy
(N=65), Group 2 – patients with mild / moderate non-
proliferative diabetic retinopathy (NPDR; N=19), and
Group 3 – patients with severe / very severe NPDR or
proliferative diabetic retinopathy (PDR; N=23).
Descriptive statistics of basic characteristics, markers
of inflammation, other markers of endothelial dysfunc-
tion, anthropometric and clinical parameters according
to the diabetic retinopathy status are presented in Table
1. There were no differences in age and sex between the
groups. Group 3 had significantly longer diabetes dura-
M. Tomi} et al.: Inflammation and Endothelial Dysfunction in Diabetic Retinopathy, Coll. Antropol. 37 (2013) Suppl. 1: 51–57
53
TABLE 1
BASIC CHARACTERISTICS, MARKERS OF INFLAMMATION, OTHER MARKERS OF ENDOTHELIAL DYSFUNCTION, ANTHROPOMETRIC









Age (years)* 66.31±8.31 68.47±7.11 66.52±7.98 0.543a 0.583a
Sex (m/f)** 65/35 42/58 74/26 0.280c 0.595c
Diabetes duration (years)* 13.22±5.08 16.11±6.01 19.35±4.60 12.498a <0.001a
Therapy (OHA/insulin)** 48/52 32/68 13/87 7.520c 0.009c
C-reactive protein (CRP) (mg/L)* 3.37±4.14 4.05±3.34 5.36±5.77 1.721a 0.184a
Fibrinogen (g/L)* 4.73±1.23 4.75±1.48 4.75±1.09 0.002a 0.998a
HbA1c (%)* 6.42±1.06 6.53±1.06 6.70±1.29 0.551a 0.578a
HbA1cmedian (%)* 6.77±0.76 7.18±0.81 7.31±0.85 2.976a 0.055a
Total cholesterol (mmol/L)* 4.96±0.85 4.87±1.27 5.05±1.05 0.178a 0.838a
HDL cholesterol (mmol/L)* 1.31±0.33 1.38±0.28 1.45±0.35 1.472a 0.234a
LDL cholesterol (mmol/L)* 2.71±0.84 2.61±0.99 2.73±0.94 0.111a 0.895a
Triglycerides (mmol/L)* 2.14±1.19 2.48±2.41 1.50±0.61 1.230a 0.066a
Body mass index (BMI) (kg/m²)* 30.77±6.06 30.91±5.28 30.12±5.33 0.129a 0.879a
Waist circumference (WC) (cm)* 107.52±14.96 108.21±12.09 107.91±12.28 0.020a 0.980a
Waist to hip ratio (WHR)* 0.96±0.08 0.96±0.07 0.97±0.07 0.162a 0.851a
Conicity index (C index)* 1.36±0.09 1.39±0.07 1.39±0.11 0.824a 0.441a
Systolic blood pressure (mmHg)* 139.00±22.97 151.32±23.85 144.35±21.18 2.267a 0.109a
Diastolic blood pressure (mmHg)* 82.15±12.90 80.26±15.50 78.70±8.15 0.691a 0.503a
statistically significant p<0.05; * X±SD; ** percentage; aANOVA, df=2; cChi-square test, df=1
Abbreviations: OHA – oral hypoglycemic agent, HbA1c – glycated hemoglobin value determined at the beginning of the study from a
single venous blood sample, HbA1cmedian – glycated hemoglobin value obtained by statistical analysis of data from the National Regis-
try for Diabetes (CroDiabNet)
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tion (19.35±4.60 years vs. 13.22±5.08 years; p<0.001)
and more often insulin than OHA therapy (87/13 % vs.
52/48 %; p=0.009) than Group 1. The three groups did
not significantly differ in the levels of inflammation
markers, other markers of endothelial dysfunction, an-
thropometric and clinical parameters.
Table 2 presents ophthalmologic parameters accord-
ing to the diabetic retinopathy status. Group 3 was found
to have significantly lower best corrected visual acuity
(BCVA) than Group 1 (0.72±0.37 vs. 0.97±0.08; p=
0.001). The presence of cataract as well as the condition
after cataract surgery (an artificial IOL implanted) were
observed significantly more often in Groups 2 and 3 than
in Group 1 (p=0.023). There were no differences in the
average intraocular pressure (IOP), presence of glau-
coma and hypertensive retinopathy between the studied
groups.
C-reactive protein was significantly positively corre-
lated with another inflammation marker fibrinogen (p=
0.022), other markers of endothelial dysfunction HbA1c
(p=0.050) and LDL cholesterol (p=0.043), and anthropo-
metric parameters BMI (p=0.038), WC (p=0.000), WHR
(p=0.030) and C index (p=0.008) (Table 3).
HbA1c was significantly positively correlated with
other markers of endothelial dysfunction total choles-
terol (p=0.022) and LDL cholesterol (p=0.010), and an-
thropometric parameters BMI (p=0.009) and WC (p=
0.047) (Table 4).
Univariate and multiple logistic regression analyses
showed that diabetes duration, insulin therapy and pro-
longed poor glycemic control (HbA1c median) were the
main predictors of retinopathy in patients with type 2 di-
abetes (Table 5). The increasing prevalence of retino-
pathy was significantly associated with longer duration
of diabetes (OR=1.17, 95%CI 1.08–1.27), even after ad-
justment for age and sex (AOR=1.2, 95%CI 1.1–1.32). In-
sulin therapy, not mandatory in type 2 diabetes but often
used in patients with prolonged diabetes duration and
poor glycemic control, increased the prevalence of
retinopathy to a significant extent (OR=3.34, 95%CI
1.38–8.09), even after adjustment for age and sex (AOR=
3.28, 95%CI 1.34–8.02). The increasing prevalence of
retinopathy was significantly related to prolonged poor
glycemic control (HbA1c median) (OR=1.76, 95%CI 1.08–
2.86), the association also remaining significant after ad-
justment for age and sex (AOR=1.84, 95%CI 1.10– 3.06).
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TABLE 2
OPHTHALMOLOGIC PARAMETERS OF TYPE 2 DIABETIC PATIENTS (N=107) DIVIDED INTO THREE GROUPS ACCORDING








BCVA (decimal)* 0.97±0.08 0.92±0.15 0.72±0.37 13.86b 0.001b
Glaucoma** 11 5 4 0.54c 0.461c
IOP (mmHg)* 13.66±1.50 13.58±1.07 13.22±0.95 0.49b 0.487b
Lens** 20/71/9 5/69/26 9/65/26 7.50c 0.023c
Hypertensive retinopathy ** 31 47 48 3.09c 0.079c
statistically significant p<0.05; * X±SD; ** percentage; b Kruskal-Wallis df=1; c Chi-square test df=2
Abbreviations: BCVA – best corrected visual acuity, IOP – intraocular pressure, Lens – clear crystalline lens/initial cataract/condition
after cataract surgery (an artificial IOL implanted)
TABLE 3
CORRELATION BETWEEN CRP AND OTHER MARKERS OF
INFLAMMATION, MARKERS OF ENDOTHELIAL DYSFUNCTION
AND ANTHROPOMETRIC PARAMETERS IN TYPE 2 DIABETIC
PATIENTS (N=107)
C-reactive protein (CRP)
Spearman R t(N-2) p
Fibrinogen 0.221 2.323 0.022
HbA1c 0.188 1.964 0.050
LDL cholesterol 0.196 2.053 0.043
Body mass index (BMI) 0.201 2.102 0.038
Waist circumference (WC) 0.331 3.595 0.000
Waist to hip ratio (WHR) 0.210 2.205 0.030
Conicity index (C index) 0.254 2.686 0.008
statistically significant p<0.05
Abbreviations: HbA1c – glycated hemoglobin value determined
at the beginning of the study from a single venous blood sample
TABLE 4
CORRELATION BETWEEN HbA1c AND OTHER MARKERS OF
INFLAMMATION MARKERS OF ENDOTHELIAL DYSFUNCTION
AND ANTHROPOMETRIC PARAMETERS IN TYPE 2 DIABETIC
PATIENTS (N=107)
HbA1c
Spearman R t(N-2) p
Total cholesterol 0.221 2.327 0.022
LDL cholesterol 0.248 2.625 0.010
Body mass index (BMI) 0.252 2.669 0.009
Waist circumference (WC) 0.193 2.014 0.047
statistically significant p<0.05
Abbreviations: HbA1c – glycated hemoglobin value determined
at the beginning of the study from a single venous blood sample
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Discussion
Type 2 diabetes is nowadays, because of its high inci-
dence and risk of macrovascular and microvascular dia-
betic complications, one of the potentially most damag-
ing diseases and biggest public health problems. Diabetic
eye disease with its complications, especially diabetic
retinopathy which leads to macular edema and retinal
neovascularization, is the leading cause of blindness and
visual dysfunction in working-aged adults in economi-
cally developed societies.
As expected, we found a significantly lower visual func-
tion, expressed by best corrected visual acuity (BCVA), in
the group of patients with severe NPDR and PDR than in
the group of patients with no retinopathy. Also, a signifi-
cantly more frequent cataract and the condition after cat-
aract surgery (an artificial IOL implanted) was observed
in the groups of patients with diabetic retinopathy (NPDR
and PDR) as compared with the group of patients with no
retinopathy. Last result is similar to other study30, and
may be explained by the activation of the polyol pathway
by intracellular hyperglycemia, which leads to the sor-
bitol-induced osmotic stress and occurrence of a typical
snowflake diabetic cataract or earlier senile cataract.
The results of our study are consistent with the litera-
ture, suggesting that diabetes duration and poor glyce-
mic control are the main predictors of the prevalence and
progression of retinopathy in patients with type 2 diabe-
tes31–33. We also found insulin therapy to be among the
main predictors of retinopathy in this type of diabetes. It
is common knowledge that insulin therapy is not manda-
tory for patients with type 2 diabetes, but in these
patients it is often necessary in progressive insulino-
penia, prolonged duration of diabetes and very poor
glycemic control. Our results are analogous to those of
the Wisconsin Epidemiologic Study of Diabetic Retino-
pathy, which reported an increased 4- and 10-year cumu-
lative incidence and significantly increased prevalence of
diabetic retinopathy in older patients on insulin therapy
than those on OHA therapy (70% vs. 39%)5.
Hypertension is another risk factor for diabetic reti-
nopathy documented in many epidemiological studies
and clinical trials. United Kingdom Prospective Diabetes
Study (UKPDS) and Appropriate Blood Pressure Control
in Diabetes (ABCD) Study have observed that strict
blood pressure control can prevent and/or limit the de-
velopment and progression of diabetic retinopathy and
visual dysfunction34,35. In our study there was no signifi-
cant difference in the level of systolic and diastolic blood
pressure between the groups according to their diabetic
retinopathy status. It is worth noting that the average
systolic blood pressure among our patients was 142.34±
23.03 mmHg and the average diastolic blood pressure
81.07±12.53 mmHg, these values being very near to
those recommended by the American and European Soci-
eties of Cardiology36,37.
Besides these notorious risk factors, overweight and
obesity are very frequently found in patients with type 2
diabetes. Obesity is a chronic, stigmatized disease whose
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TABLE 5
ODDS RATIOS (95% CIs) FOR DIABETIC RETINOPATHY ASSOCIATED WITH BASIC CHARACTERISTICS, INFLAMMATION MARKERS,
OTHER MARKERS OF ENDOTHELIAL DYSFUNCTION, ANTHROPOMETRIC AND CLINICAL PARAMETERS OF TYPE 2 DIABETIC
PATIENTS (N=107)
OR 95%CI (OR) AOR* 95%CI (AOR)
Diabetes duration (years) 1.17 1.08–1.27 1.20 1.10–1.32
Therapy (insulin) 3.34 1.38–8.09 3.28 1.34–8.02
C reactive protein (CRP) 1.07 0.98–1.18 1.08 0.99–1.18
Fibrinogen 1.01 0.74–1.38 0.99 0.71–1.37
HbA1c 1.18 0.83–1.68 1.23 0.85–1.77
HbA1c median 1.76 1.08–2.86 1.84 1.10–3.06
Total cholesterol 1.01 0.68–1.51 1.03 0.68–1.57
HDL cholesterol 2.65 0.79–8.85 2.51 0.69–9.06
LDL cholesterol 1.01 1.00–1.02 1.01 1.00–1.02
Triglycerides 0.89 0.69–1.13 0.90 0.70–1.15
Body mass index (BMI) 0.99 0.93–1.06 0.99 0.92–1.07
Waist circumference (WC) 1.00 0.97–1.03 1.01 0.98–1.04
Waist to hip ratio (WHR) 1.34 0.01–185.05 7.42 0.14–3806.64
Conicity index (C index) 15.02 0.23–965.31 21.22 0.29–1544.61
Systolic blood pressure 1.02 1.00–1.03 1.02 1.00–1.04
Diastolic blood pressure 0.98 0.95–1.01 0.98 0.95–1.02
statistically significant p<0.05; *OR adjusted for age and sex
Abbreviations: HbA1c – glycated hemoglobin value determined at the beginning of the study from a single venous blood sample, HbA1c
median – glycated hemoglobin value obtained by statistical analysis of data from the National Registry for Diabetes (CroDiabNet)
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prevalence has risen progressively over the last 20 years38.
It increases the risk of type 2 diabetes and is connected
with insulin resistance, hyperinsulinemia and hyperlipi-
demia39. Many studies support the correlation between
obesity expressed by BMI and deterioration of HbA1c, de-
crease in HDL cholesterol, increase in triglycerides and a
higher prevalence of hypertension and cardiovascular
disease40,41. Some other studies have found a correlation
between obesity and diabetic microvascular complica-
tions in patients with type 2 diabetes8,33. New data sug-
gest that adipose tissue is an important determinant of a
low-level, chronic inflammatory state reflected by the
production of various proinflammatory cytokines, which
induce insulin resistance and endothelial dysfunction,
consequently linking the later phenomenon with obesity
and diabetic angiopathy42. Several authors have shown
that elevated plasma levels of fibrinogen, C–reactive pro-
tein and interleukin-6 are associated with the risk of car-
diovascular disease and the severity of atherosclerosis43,44.
The Hoorn Study found a positive association between
the levels of C-reactive protein and soluble intracellular
adhesion molecule-1 (sICAM-1) and the prevalence of di-
abetic retinopathy17.
In our study there was no significant difference in the
levels of inflammation markers, other markers of endo-
thelial dysfunction and anthropometric parameters be-
tween the groups according to the diabetic retinopathy
status. The lack of difference in the levels of inflamma-
tion markers and other markers of endothelial dysfunc-
tion in our study could be due to the sample size and to
the fact that the majority of our patients had near nor-
mal values of these markers. However, we observed a
positive correlation of the inflammation marker C-reac-
tive protein with another inflammation marker fibri-
nogen, other markers of endothelial dysfunction HbA1c
and LDL cholesterol, and the anthropometric parame-
ters BMI, WC, WHR and C index. We also found a posi-
tive correlation of the endothelial dysfunction marker
HbA1c with other markers of endothelial dysfunction to-
tal cholesterol and LDL cholesterol, and with the anthro-
pometric parameters BMI and WC.
Conclusion
Diabetes duration, prolonged poor glycemic control
and the resulting need for insulin therapy are the main
predictors of retinopathy in patients with type 2 diabe-
tes. The positive correlation of C-reactive protein with
fibrinogen, HbA1c, LDL cholesterol and anthropometric
parameters BMI, WC, WHR and C index, as well as the
positive correlation of HbA1c with total cholesterol, LDL
cholesterol and anthropometric parameters BMI and WC
suggests that the association between obesity, inflamma-
tion and other risk factors plays an important role in en-
dothelial impairment involved in the pathogenesis of dia-
betic retinopathy. These findings point to the need for
testing the effects of treatment aimed at decreasing in-
flammatory activity and improving endothelial function
as a means of preventing or limiting the progression of
retinopathy.
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ULOGA UPALNIH ^IMBENIKA I ENDOTELNE DISFUNKCIJE U RAZVOJU DIJABETI^KE
RETINOPATIJE
S A @ E T A K
Etiopatogeneza dijabeti~ke retinopatije (DR) je nedovoljno razja{njena, no pretpostavlja se da u njoj va`nu ulogu
imaju upalni ~imbenici i endotelna disfunkcija. Cilj istra`ivanja bio je ispitati povezanost upalnih ~imbenika s ostalim
~imbenicima endotelnog o{te}enja i antropometrijskim parametrima, te njihovu povezanost sa stupnjem DR kod boles-
nika sa {e}ernom bole{}u tipa 2 podijeljenih u tri skupine: bez retinopatije (N=65), s blagom / umjereno te{kom neproli-
ferativnom dijabeti~kom retinopatijom (NPDR; N=19) i te{kom NPDR / proliferativnom dijabeti~kom retinopatijom
(PDR; N=23). Me|u skupinama nije bilo zna~ajne razlike u razini upalnih i ostalih ~imbenika endotelnog o{te}enja, te
vrijednostima antropometrijskih parametara. C-reaktivni protein bio je pozitivno povezan s fibrinogenom, HbA1c,
LDL-kolesterolom, BMI, WC, WHR i C indeksom, a HbA1c s kolesterolom, LDL-kolesterolom, BMI i WC. Logisti~ka
regresija je trajanje dijabetesa i HbA1cmedian izdvojila kao glavne pretkazatelje razvoja retinopatije. Ovo istra`ivanje
ukazalo je na va`nost povezanosti pretilosti, upalnih i ostalih ~imbenika endotelne disfunkcije u razvoju dijabeti~ke
retinopatije.
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